Related Articles
Axcella Health Inc (NASDAQ:AXLA) Director David R. Epstein purchased 4,556 shares of the firm’s stock in a transaction that occurred on Wednesday, July 3rd. The shares were bought at an average price of $8.76 per share, with a total value of $39,910.56. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
AXLA traded up $0.60 during midday trading on Friday, hitting $8.08. 6,900 shares of the company’s stock traded hands, compared to its average volume of 36,709. The company’s fifty day moving average price is $9.62. Axcella Health Inc has a one year low of $6.83 and a one year high of $15.99.
Axcella Health (NASDAQ:AXLA) last issued its quarterly earnings data on Thursday, June 20th. The company reported ($2.43) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($2.04). As a group, research analysts expect that Axcella Health Inc will post -3.05 EPS for the current year.
Several analysts recently commented on the stock. JPMorgan Chase & Co. upgraded shares of ROYAL MAIL PLC/ADR from an “underweight” rating to a “neutral” rating in a report on Monday, June 3rd. Svb Leerink started coverage on shares of Trevi Therapeutics in a research report on Monday, June 3rd. They set an “outperform” rating and a $14.00 price objective on the stock. Goldman Sachs Group started coverage on shares of Axcella Health in a research report on Sunday, June 2nd. They set a “buy” rating and a $25.00 price objective on the stock. Finally, Leerink Swann started coverage on shares of Trevi Therapeutics in a research report on Monday, June 3rd. They set an “outperform” rating on the stock.
About Axcella Health
There is no company description available for Axcella Health Inc
Recommended Story: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Axcella Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axcella Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source link
